Globe Life stock reports an ex-dividend date and Q2 growth

Published on 10/05/2026 at 15:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Globe Life stock entered its October 5, 2026 ex-dividend date with a USD 0.33 payout. Second-quarter revenue reached USD 1.60 billion, while EPS missed consensus.

Extreme Makroaufnahme einer Lebensversicherungspolice mit goldenem Prägesiegel und Wasserzeichen — Globe Life Inc. Makroaufnahme einer Lebensversicherungspolice mit goldenem Prägesiegel auf Papier, ISIN US37959E1029, Illustration mit AI erstellt.

Globe Life stock (ISIN US37959E1029) closed at USD 165.90 on the NYSE on October 2, 2026, while the insurer entered its October 5 ex-dividend date with a USD 0.33 quarterly payment. The immediate investor focus is the contrast between 8.0 percent revenue growth and an earnings miss in the latest reported quarter.

Ex-dividend date sets the near-term marker

According to aktiencheck.de on October 5, 2026, Globe Life was scheduled to trade ex-dividend for the USD 0.33 payment. The payment date is October 30, 2026, and the quarterly amount corresponds to USD 1.32 on an annualized basis, according to MarketBeat.

The ex-dividend date is a concrete calendar marker rather than a new operating update. Globe Life's payout ratio was reported at 8.76 percent, leaving the dividend smaller than the company's earnings profile.

Revenue growth outpaced EPS expectations

Globe Life reported second-quarter 2026 operating revenue of USD 1.60 billion, up 8.0 percent from the comparable period, while net operating income reached USD 3.61 per share. Zacks reported on September 7, 2026, that the figure missed consensus of USD 3.67 by 1.6 percent.

The operating split explains the mixed signal. Total premium revenue increased 7.0 percent to USD 1.30 billion, with life premiums rising 3.0 percent to USD 860.8 million and health premiums advancing 16.0 percent to USD 436.9 million, according to Zacks.

Globe Life raised its full-year 2026 net operating income guidance to USD 15.55-15.95 per share, with the midpoint increasing by USD 0.10 from the prior outlook, Zacks reported. The next earnings date is listed as October 22, 2026 by StockHub.

Consensus target remains above the stock

MarketBeat reported on September 17, 2026, that eleven analysts held a Moderate Buy consensus, with eight Buy ratings, one Strong Buy rating and two Holds. The average 12-month price target was USD 191.67, compared with the October 2 closing price of USD 165.90.

That gap places the consensus target USD 25.77 above the closing price, while the stock's market capitalization was USD 13.3 billion. The shares remained below the 52-week high of USD 191.55 and above the 52-week low of USD 127.85 on the same quoted market overview.

Globe Life stock closes at USD 165.90

Globe Life stock closed at USD 165.90 on the NYSE on October 2, 2026, with a 52-week range of USD 127.85 to USD 191.55 and market capitalization of USD 13.3 billion.